Literature DB >> 23184524

M-ficolin binds selectively to the capsular polysaccharides of Streptococcus pneumoniae serotypes 19B and 19C and of a Streptococcus mitis strain.

Troels R Kjaer1, Annette G Hansen, Uffe B S Sørensen, Anne T Holm, Grith L Sørensen, Jens C Jensenius, Steffen Thiel.   

Abstract

The three human ficolins (H-, L-, and M-ficolins) and mannan-binding lectin are pattern recognition molecules of the innate immune system mediating activation of the lectin pathway of the complement system. These four human proteins bind to some microorganisms and may be involved in the resolution of infections. We investigated binding selectivity by examining the binding of M-ficolin to a panel of more than 100 different streptococcal strains (Streptococcus pneumoniae and Streptococcus mitis), each expressing distinct polysaccharide structures. M-ficolin binding was observed for three strains only: strains of the pneumococcal serotypes 19B and 19C and a single S. mitis strain expressing a similar polysaccharide structure. The bound M-ficolin, in association with MASP-2, mediated the cleavage of complement factor C4. Binding to the bacteria was inhibitable by N-acetylglucosamine, indicating that the interaction with the bacterial surface takes place via the fibrinogen-like domain. The common N-acetylmannosamine residue present in the structures of the four capsular polysaccharides of group 19 is linked via a phosphodiester bond. This residue is apparently not a ligand for M-ficolin, since the lectin binds to two of the group 19 polysaccharides only. M-ficolin bound strongly to serotype 19B and 19C polysaccharides. In contrast to those of serotypes 19A and 19F, serotype 19B and 19C polysaccharides contain an extra N-acetylmannosamine residue linked via glycoside linkage only. Thus, this extra residue seems to be the M-ficolin ligand. In conclusion, we were able to demonstrate specific binding of M-ficolin to some capsular polysaccharides of the opportunistic pathogen S. pneumoniae and of the commensal bacterium S. mitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184524      PMCID: PMC3553806          DOI: 10.1128/IAI.01148-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  M-ficolin is expressed on monocytes and is a lectin binding to N-acetyl-D-glucosamine and mediates monocyte adhesion and phagocytosis of Escherichia coli.

Authors:  C Teh; Y Le; S H Lee; J Lu
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

2.  Inherited deficiency of mannan-binding lectin-associated serine protease 2.

Authors:  Kristian Stengaard-Pedersen; Steffen Thiel; Mihaela Gadjeva; Mette Møller-Kristensen; Rikke Sørensen; Lise T Jensen; Anders G Sjøholm; Lars Fugger; Jens C Jensenius
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

3.  L-ficolin is a pattern recognition molecule specific for acetyl groups.

Authors:  Anders Krarup; Steffen Thiel; Annette Hansen; Teizo Fujita; Jens C Jensenius
Journal:  J Biol Chem       Date:  2004-08-25       Impact factor: 5.157

4.  Cloning and characterization of the human lectin P35 gene and its related gene.

Authors:  Y Endo; Y Sato; M Matsushita; T Fujita
Journal:  Genomics       Date:  1996-09-15       Impact factor: 5.736

5.  An assay for the mannan-binding lectin pathway of complement activation.

Authors:  S V Petersen; S Thiel; L Jensen; R Steffensen; J C Jensenius
Journal:  J Immunol Methods       Date:  2001-11-01       Impact factor: 2.303

6.  Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin.

Authors:  Anders Krarup; Uffe B Skov Sørensen; Misao Matsushita; Jens C Jensenius; Steffen Thiel
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

7.  Characterization of ficolins as novel elastin-binding proteins and molecular cloning of human ficolin-1.

Authors:  S Harumiya; K Takeda; T Sugiura; Y Fukumoto; H Tachikawa; K Miyazono; D Fujimoto; H Ichijo
Journal:  J Biochem       Date:  1996-10       Impact factor: 3.387

8.  Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9.

Authors:  J Lu; P N Tay; O L Kon; K B Reid
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

Review 9.  Streptococcus pneumoniae colonisation: the key to pneumococcal disease.

Authors:  D Bogaert; R De Groot; P W M Hermans
Journal:  Lancet Infect Dis       Date:  2004-03       Impact factor: 25.071

10.  Mice deficient in ficolin, a lectin complement pathway recognition molecule, are susceptible to Streptococcus pneumoniae infection.

Authors:  Yuichi Endo; Minoru Takahashi; Daisuke Iwaki; Yumi Ishida; Naomi Nakazawa; Toshihisa Kodama; Tomohiro Matsuzaka; Kazuko Kanno; Yu Liu; Kohsuke Tsuchiya; Ikuo Kawamura; Masahito Ikawa; Satoshi Waguri; Ikuo Wada; Misao Matsushita; Wilhelm J Schwaeble; Teizo Fujita
Journal:  J Immunol       Date:  2012-11-12       Impact factor: 5.422

View more
  13 in total

1.  Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.

Authors:  Allison M Brady; Juan J Calix; Jigui Yu; Kimball Aaron Geno; Gary R Cutter; Moon H Nahm
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

2.  M-ficolin is present in Aspergillus fumigatus infected lung and modulates epithelial cell immune responses elicited by fungal cell wall polysaccharides.

Authors:  Kasper Jensen; Kit P Lund; Kimmie B Christensen; Anne T Holm; Lalit Kumar Dubey; Jesper B Moeller; Christine S Jepsen; Anders Schlosser; László Galgóczy; Steffen Thiel; Uffe Holmskov; Grith L Sorensen
Journal:  Virulence       Date:  2017-02-16       Impact factor: 5.882

3.  Interaction of lectin pathway of complement-activating pattern recognition molecules with mycobacteria.

Authors:  M A Bartlomiejczyk; A S Swierzko; A Brzostek; J Dziadek; M Cedzynski
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

Review 4.  Pneumococcal Capsules and Their Types: Past, Present, and Future.

Authors:  K Aaron Geno; Gwendolyn L Gilbert; Joon Young Song; Ian C Skovsted; Keith P Klugman; Christopher Jones; Helle B Konradsen; Moon H Nahm
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Intranasal Immunization with the Commensal Streptococcus mitis Confers Protective Immunity against Pneumococcal Lung Infection.

Authors:  Sudhanshu Shekhar; Rabia Khan; Karl Schenck; Fernanda Cristina Petersen
Journal:  Appl Environ Microbiol       Date:  2019-03-06       Impact factor: 4.792

6.  Protective role of the capsule and impact of serotype 4 switching on Streptococcus mitis.

Authors:  Håkon V Rukke; Raja Sab Kalluru; Urska Repnik; Alice Gerlini; Ricardo J José; Jimstan Periselneris; Helina Marshall; Gareth Griffiths; Marco Rinaldo Oggioni; Jeremy S Brown; Fernanda C Petersen
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

7.  A recombinant horseshoe crab plasma lectin recognizes specific pathogen-associated molecular patterns of bacteria through rhamnose.

Authors:  Sim-Kun Ng; Yu-Tsyr Huang; Yuan-Chuan Lee; Ee-Ling Low; Cheng-Hsun Chiu; Shiu-Ling Chen; Liang-Chi Mao; Margaret Dah-Tsyr Chang
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

8.  Anatomical site-specific contributions of pneumococcal virulence determinants.

Authors:  Anukul T Shenoy; Carlos J Orihuela
Journal:  Pneumonia (Nathan)       Date:  2016-06-03

9.  Mannose-binding lectin-associated serine protease 2 (MASP-2) contributes to poor disease outcome in humans and mice with pneumococcal meningitis.

Authors:  E Soemirien Kasanmoentalib; Mercedes Valls Seron; Bart Ferwerda; Michael W Tanck; Aeilko H Zwinderman; Frank Baas; Arie van der Ende; William J Schwaeble; Matthijs C Brouwer; Diederik van de Beek
Journal:  J Neuroinflammation       Date:  2017-01-03       Impact factor: 8.322

10.  Ficolins do not alter host immune responses to lipopolysaccharide-induced inflammation in vivo.

Authors:  Ninette Genster; Olga Østrup; Camilla Schjalm; Tom Eirik Mollnes; Jack B Cowland; Peter Garred
Journal:  Sci Rep       Date:  2017-06-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.